Tolvaptan

(Synonyms: 托伐普坦; OPC-41061)
目录号: PL04689 纯度: ≥99%
Tolvaptan 是一种选择性,竞争性并且具有口服活性的 vasopressin receptor 2 (V2R) 拮抗剂,抑制 AVP 诱导的血小板聚集,其 IC50 值为 1.28 μM。Tolvaptan 可诱导细胞凋亡,影响细胞周期。Tolvaptan 可用于低钠血症的研究。
CAS No. :150683-30-0
商品编号 规格 价格 会员价 是否有货 数量
PL04689-1mg 1mg ¥237.00 请登录
PL04689-2mg 2mg ¥338.00 请登录
PL04689-5mg 5mg ¥552.00 请登录
PL04689-10mg 10mg ¥892.00 请登录
PL04689-50mg 50mg ¥2875.00 请登录
PL04689-100mg 100mg 询价 询价
PL04689-200mg 200mg 询价 询价
PL04689-10mM*1mLinDMSO 10mM*1mLinDMSO ¥1909.00 请登录
PL04689-1 mL x 10 mM (in DMSO) ¥647.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
*注意事项:下单时请联系销售核实产品价格及货期,避免后续产生不便,感谢支持!
中文名称
Tolvaptan
中文别名
托伐普坦;N-[4-[(5R)-7-氯-5-羟基-2,3,4,5-四氢-1-苯并氮杂卓-1-甲酰基]-3-甲基苯基]-2-甲基苯甲酰胺;托伐普坦-D7;托伐普坦标准品;托伐普坦杂质;盐酸帕唑替尼;托伐普坦(标准品)
英文名称
Tolvaptan
英文别名
N-(4-(7-Chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)-3-methylphenyl)-2-methylbenzamide;Tolvaptan;N-[4-[(5R)-7-Chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl]-3-methylphenyl]-2-methylbenzamide;N-(4-(7-Chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-benzo[b]-azepine-1-carbonyl)-3-methylphenyl)-2-methylbenzamide;N-[4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methylphenyl]-2-methylbenzamide;N-[4-(9-chloro-6-hydroxy-2-azabicyclo[5.4.0]undeca-8,10,12-triene-2-carbonyl)-3-methyl-phenyl]-2-methyl-benzamide;N-[4-[(7-chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl)carbonyl]-3-methylphenyl]-2-methylBenzamide;benzazepine derivative,32;OPC 41061;OPC-41061;Samsca;UNII-21G72T1950;Tolvptan;TOIVAPTAN;Tolvaptan-d7;Tolvaptan Tablets;pazopanib hydrochloeide;Best Price Tolvaptan from China CAS NO.150683-30-0;C26H25ClN2O3;Benzamide, N-(4-((7-chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl)carbonyl)-3-methylphenyl)-2-methyl-;benzazepine derivative, 32;Tolvaptan [USAN:INN:BAN]
Cas No.
150683-30-0
分子式
C26H25ClN2O3
分子量
448.94
包装储存
Powder -20°C 3 years;4°C 2 years
详情描述

Tolvaptan 是一种选择性,竞争性并且具有口服活性的 vasopressin receptor 2 (V2R) 拮抗剂,抑制 AVP 诱导的血小板聚集,其 IC50 值为 1.28 μM。Tolvaptan 可诱导细胞凋亡,影响细胞周期。Tolvaptan 可用于低钠血症的研究。

产品详情
Tolvaptan 是一种选择性,竞争性并且具有口服活性的 vasopressin receptor 2 (V2R) 拮抗剂,抑制 AVP 诱导的血小板聚集,其 IC50 值为 1.28 μM。Tolvaptan 可诱导细胞凋亡,影响细胞周期。Tolvaptan 可用于低钠血症的研究。
生物活性
Tolvaptan is a selective, competitive and orally active vasopressin receptor 2 (V 2 R) antagonist with an IC 50 of 1.28 μM for the inhibition of arginine vasopressin (AVP)-induced platelet aggregation. Tolvaptan induces cell apoposis and affects cell cycle. Tolvaptan can be used for the research of hyponatremia.
性状
Solid
体外研究(In Vitro)
Tolvaptan (0-100 μM; 24-168 h) decreases the growth of HepG2 cells.
Tolvaptan (20-100 μM; 24-48 h) induces cell death in HepG2 cells.
Tolvaptan (0-100 μM; 24-48 h) affects cell cycle of HepG2 cells.
Tolvaptan (0-100 μM; 24-48 h) causes DNA damage and induces apoptosis of HepG2 cells.
Tolvaptan (0-100 μM; 24-48 h) decreases cyclins and CDKs, and increases γ-H2AX, PARP cleavage and LC3B-II in HepG2 cells.
Tolvaptan (0-100 μM; 4-24 h) induces phosphorylation of JNK, ERK1/2 and p38 in HepG2 cells.
Tolvaptan (0-100 μM; 24-28 h) induces autophagy of HepG2 cells. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
Tolvaptan (10 mg/kg; p.o. once per day for 22 days) improves cyclophosphamide (CP)-induced nephrotoxicity in rats. has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Male albino rats wit
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
ClinicalTrial
参考文献
[1]. Wu Y, et al. Mechanisms of tolvaptan-induced toxicity in HepG2 cells. Biochem Pharmacol. 2015 Jun 15;95(4):324-36.
[2]. El-Shabrawy M, et al. Protective effect of tolvaptan against cyclophosphamide-induced nephrotoxicity in rat models. Pharmacol Res Perspect. 2020 Oct;8(5):e00659.
溶解度数据
In Vitro: DMSO : ≥ 100 mg/mL (222.75 mM)配制储备液
搜索质检报告(COA)
[1]. Wu Y, et al. Mechanisms of tolvaptan-induced toxicity in HepG2 cells. Biochem Pharmacol. 2015 Jun 15;95(4):324-36.
[2]. El-Shabrawy M, et al. Protective effect of tolvaptan against cyclophosphamide-induced nephrotoxicity in rat models. Pharmacol Res Perspect. 2020 Oct;8(5):e00659.

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

相关产品

更多
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2